S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
pixel
Log in

Activision Blizzard (NASDAQ:ATVI) Price Target Raised to $115.00 at Deutsche Bank Aktiengesellschaft

Last updated on Thursday, February 25, 2021 | 2021 MarketBeat

Activision Blizzard (NASDAQ:ATVI) had its price objective upped by equities researchers at Deutsche Bank Aktiengesellschaft from $100.00 to $115.00 in a research report issued on Thursday. The brokerage presently has a "buy" rating on the stock. Deutsche Bank Aktiengesellschaft's price target would indicate a potential upside of 20.13% from the company's current price.

Other equities analysts have also issued reports about the company. JPMorgan Chase & Co. raised their price target on Activision Blizzard from $101.00 to $115.00 and gave the stock an "overweight" rating in a research report on Friday, February 5th. Morgan Stanley lifted their target price on shares of Activision Blizzard from $108.00 to $115.00 and gave the stock an "overweight" rating in a research note on Friday, February 5th. BMO Capital Markets increased their price target on shares of Activision Blizzard from $80.00 to $104.00 and gave the company a "market perform" rating in a research report on Tuesday, February 9th. Citigroup raised their price target on shares of Activision Blizzard from $83.00 to $110.00 in a report on Friday, February 19th. Finally, Truist upped their price objective on shares of Activision Blizzard from $90.00 to $100.00 in a research note on Tuesday, February 2nd. Four investment analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the stock. The stock presently has an average rating of "Buy" and an average target price of $102.23.

NASDAQ:ATVI traded up $0.04 during trading hours on Thursday, reaching $95.73. The company's stock had a trading volume of 63,020 shares, compared to its average volume of 6,033,008. The firm has a market capitalization of $73.99 billion, a price-to-earnings ratio of 33.53, a PEG ratio of 1.72 and a beta of 0.71. The firm has a 50-day simple moving average of $95.46 and a 200-day simple moving average of $84.99. Activision Blizzard has a 1 year low of $50.51 and a 1 year high of $104.53. The company has a debt-to-equity ratio of 0.25, a quick ratio of 4.12 and a current ratio of 4.12.

Activision Blizzard (NASDAQ:ATVI) last posted its quarterly earnings results on Wednesday, February 3rd. The company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.18 by $0.03. Activision Blizzard had a net margin of 28.90% and a return on equity of 19.07%. During the same quarter last year, the business earned $1.23 earnings per share. Equities analysts anticipate that Activision Blizzard will post 3.22 earnings per share for the current fiscal year.

In other Activision Blizzard news, Director Casey Wasserman sold 10,000 shares of Activision Blizzard stock in a transaction on Friday, December 4th. The stock was sold at an average price of $80.75, for a total transaction of $807,500.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.13% of the stock is currently owned by insiders.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Ropes Wealth Advisors LLC bought a new position in Activision Blizzard in the 4th quarter worth about $29,000. Fieldpoint Private Securities LLC purchased a new position in Activision Blizzard in the fourth quarter worth about $29,000. Advisory Alpha LLC bought a new position in shares of Activision Blizzard in the third quarter worth approximately $25,000. Freedman Financial Associates Inc. bought a new position in shares of Activision Blizzard in the fourth quarter worth approximately $32,000. Finally, Clearview Wealth Advisors LLC purchased a new stake in shares of Activision Blizzard during the fourth quarter valued at approximately $40,000. 85.77% of the stock is owned by hedge funds and other institutional investors.

About Activision Blizzard

Activision Blizzard, Inc, together with its subsidiaries, develops and distributes content and services on video game consoles, personal computers (PC), and mobile devices in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates through three segments: Activision Publishing, Inc; Blizzard Entertainment, Inc; and King Digital Entertainment.

Recommended Story: How a Put Option Works

Analyst Recommendations for Activision Blizzard (NASDAQ:ATVI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to conta[email protected]


15 Healthcare Stocks that Analysts Love

There are more than 200 healthcare companies traded on public markets. Given the sheer number of pharmaceutical companies, medical research firms, hospital systems, and other healthcare stocks, it can be hard to identify which healthcare companies will outperform the market.

Fortunately, Wall Street's brightest minds have already done this for us. Every year, analysts issue approximately 3,000 distinct recommendations for healthcare companies. Analysts don't always get their "buy" ratings right, but it's worth taking a hard look when several analysts from different brokerages and research firms are giving "strong-buy" and "buy" ratings to the same healthcare stock.

This slide show lists the 15 healthcare companies with the highest average analyst recommendations from Wall Street's equities research analysts over the last 12 months.

View the "15 Healthcare Stocks that Analysts Love".

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.